![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
Hospital Authority, Hong Kong Pfizer |
---|---|
Information provided by: | Hospital Authority, Hong Kong |
ClinicalTrials.gov Identifier: | NCT00577967 |
To investigate using the drug gabapentin to relieve the intense pruritic sensation associated with chronic renal failure patients undergoing peritoneal dialysis.
Condition | Intervention |
---|---|
Pruritus Uremia |
Drug: Gabapentin |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Gabapentin - A Solution to Uremic Pruritus? A Prospective, Randomized, Placebo-Controlled, Double-Blind Study |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contact: Yui Pong Siu, Dr | (852) 2468 5750 | maryvil@netivigator.com |
China | |
Tuen Mun Hospital | |
Hong Kong, China |
Principal Investigator: | Yui Pong Siu, Dr | Medical and Geriatrics / Nephrology, Tuen Mun Hospital |
Study ID Numbers: | 355/05, HARECCTR0500020 |
Study First Received: | December 19, 2007 |
Last Updated: | December 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00577967 |
Health Authority: | Hong Kong: Ethics Committee |
Uremic pruritis |
Pruritus Excitatory Amino Acids Calcium, Dietary Signs and Symptoms |
Skin Diseases Gabapentin Uremia |
Skin Manifestations Neurotransmitter Agents Tranquilizing Agents Molecular Mechanisms of Pharmacological Action Anti-Dyskinesia Agents Physiological Effects of Drugs Psychotropic Drugs Central Nervous System Depressants Antiparkinson Agents Calcium Channel Blockers Excitatory Amino Acid Agents Cardiovascular Agents |
Antimanic Agents Pharmacologic Actions Membrane Transport Modulators Sensory System Agents Therapeutic Uses Anti-Anxiety Agents Analgesics Peripheral Nervous System Agents Central Nervous System Agents Anticonvulsants Excitatory Amino Acid Antagonists |